Timely publishing of experiences and sharing of knowledge. by O'Connell, Nuala H. et al.
Accepted Manuscript
Timely publishing of experiences and sharing of knowledge
Nuala H. O’Connell, Paul Tansey, Suzanne S. Dunne, Colum P. Dunne
PII: S0195-6701(17)30375-4
DOI: 10.1016/j.jhin.2017.06.028
Reference: YJHIN 5151
To appear in: Journal of Hospital Infection
Received Date: 24 June 2017
Accepted Date: 26 June 2017
Please cite this article as: O’Connell NH, Tansey P, Dunne SS, Dunne CP, Timely publishing
of experiences and sharing of knowledge, Journal of Hospital Infection (2017), doi: 10.1016/
j.jhin.2017.06.028.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Letter to the Editor 
 
Timely publishing of experiences and sharing of knowledge.  
 
Sir, 
Philip Larkin wrote “man hands on misery to man”. The poet was born in 1922  at the 
birth of the modern “antibiotic era” and, while he was not referring to infection, the 
phrase reflects the microbiological phenomenon. Early career doctors, nurses and 
IPC professionals should feel empowered to report their work and not be over-awed 
by perceived restrictions or hierarchical clinical and management structures. 
However, their early career focus is likely to be dominated by ambition for 
professional success. Controversy, “rocking of boats” and  association with incidents 
of emerging drug resistance may, perhaps, be viewed as best avoided. And such 
was the case, in 2005, when a 15 year old male cystic fibrosis patient presented with 
a linezolid-resistant methicillin-sensitive Staphylococcus aureus G2576T mutation 
secondary to the prolonged use of linezolid by his attending physican in the absence 
of any specialist advice. Although now superceded by reports in 2006 and  2010 1,2  
of similar incidences, at that time we did not publish our learning regarding risks 
associated with prolonged monotherapy in this setting, ineffective dosing and 
subsequent bacteriostatic activity. 
 
We aspire to treat our patients; but when constrained by time and resources we risk 
ignoring the broad meaning of the term. We fail to treat in the academic sense, to 
reflect and to pursue intellectual work that ensures we scientifically analyse, interpret 
and report our findings in ways that disseminate data and contribute to the body of 
knowledge regarding clinical challenges and innovative solutions. 
 
Reflecting on our recent reports documenting incidences of multidrug-resistant 
microbes, management of their outbreaks, interventions for their avoidance, and 
patient experiences when identified as carriers, it is apparent that this activity 
corresponded with the appointment to Univesity Hospital Limerick in 2010 of a 
second consultant clinical microbiologist 3-5. This created some capacity to assess 
our practice, to engage with the research strategy of the nascent affiliated medical 
school, and to publish.  
 
Infection prevention and control represents a community of practice in which to 
become professionally isolated can result in poor clinical performance and, 
inevitably, patient outcomes. In the “post-antibioic era”, the consequences of not 
publishing emerging pathogens and their characteristics in a timely fashion are too 
grave. It behoves us as mentors and colleagues to enable this, and to ensure that 
dissemination of our learnings are not delayed to the detriment of patients. Maybe 
Larkin’s “men” can instead be vectors of knowledge. 
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